Legend Biotech Corporation Sponsored ADR

LEGN Healthcare Biotechnology

Legend Biotech Corporation Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $1.0 billion, up 64.0% from fiscal 2024. In the quarter to June 2026, revenue grew 51.9%, EPS grew 126.1%, free cash flow fell 26.8% and total debt fell 49.6%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

18.48 1.32 −6.67%
Market cap
$3.8B
P/E
0.0×
Fwd P/E
112×
Dividend yield
—
F-score
3/9
Altman Z
4.54
Beneish M
−2.08
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Total current assets
1,247.10 1,283.90 1,497.80 1,099.12 949.85 592.86 207.10 326.96 231.00
Total non-current assets
486.60 386.30 350.81 231.84 169.62 128.15 80.61 102.09 —
Total Assets
1,733.70 1,670.20 1,848.61 1,330.96 1,119.47 721.01 287.72 429.05 —
Total current liabilities
636.40 277.70 216.42 297.79 229.20 161.17 127.76 159.19 52.00
Total non-current liabilities
95.20 351.90 380.82 288.86 124.32 279.59 282.82 261.21 —
Total liabilities
731.60 629.60 597.24 586.65 353.52 440.75 410.58 420.40 227.00
Common Equity (Total)
1,002.10 1,040.60 1,251.37 744.31 765.94 280.26 (122.87) 8.65 12.00
Shareholders Equity (Total)
1,002.10 1,040.60 1,251.37 744.31 765.94 280.26 (122.87) 8.65 12.00
Total Debt
319.10 301.20 281.33 264.93 121.46 4.00 6.00 5.00 0.00

Show all line items

In millions of $ except per-share values · columns are period end dates